Latest news
Tempus AI Stock Drops As $1.5B Personalis Deal Ups The MRD Stakes - StocksToTradeStocksToTrade · Sat, 08 Aug 2026 12:37:00 GMTPersonalis (PSNL) Is Up 6.1% After Q2 Revenue Rises But Losses Deepen - What's Changed - simplywall.stsimplywall.st · Fri, 07 Aug 2026 15:47:13 GMTCancer Detection Test Receives Regulatory Marking for Use in Great Britain - Clinical Lab ProductsClinical Lab Products · Fri, 07 Aug 2026 13:39:57 GMTLake Street Maintains Personalis(PSNL.US) With Hold Rating, Maintains Target Price $16.25 - MoomooMoomoo · Thu, 06 Aug 2026 03:21:08 GMTIs Personalis Inc (PSNL) Significantly Overvalued Even After Q2 Revenue of $22.4 Million? GF Score: 59/100 - GuruFocusGuruFocus · Tue, 04 Aug 2026 23:40:37 GMTPersonalis : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 22:40:58 GMTPersonalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 21:15:03 GMTPersonalis, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 20:48:23 GMT